Spritam Drug Interactions: What to Avoid and What to Tell Your Doctor

One of levetiracetam's most clinically important advantages is its relatively clean drug interaction profile. Unlike many older antiepileptic drugs that are major CYP450 enzyme inducers or inhibitors — causing cascading interactions with dozens of medications — levetiracetam has minimal pharmacokinetic drug interactions. This makes Spritam an attractive choice for patients on complex medication regimens. However, there are still important interactions to know about, particularly with CNS depressants.

Why Levetiracetam Has Fewer Interactions Than Most AEDs

Many antiepileptic drugs are metabolized through the liver's CYP450 enzyme system. When a drug strongly induces or inhibits these enzymes, it can dramatically alter how other drugs are metabolized — making some medications more or less effective, and sometimes causing dangerous interactions.

Levetiracetam is different. It has minimal CYP450 enzyme metabolism and is primarily excreted unchanged through the kidneys. This means it doesn't meaningfully affect the blood levels of other drugs that rely on liver metabolism, and other drugs don't significantly affect levetiracetam levels either. This is a significant advantage compared to drugs like carbamazepine, phenytoin, valproate, and phenobarbital, which have extensive interaction profiles.

Interactions to Be Aware Of

Even though the interaction profile is relatively clean, there are meaningful interactions to discuss with your doctor:

1. CNS Depressants (Major — Avoid or Use With Extreme Caution)

This is the most important category of Spritam interactions. Combining levetiracetam with other drugs that cause CNS (central nervous system) depression results in additive or synergistic sedation. This can cause excessive sleepiness, impaired coordination, slowed breathing, and in severe cases, respiratory depression.

CNS depressants include:

Opioid pain medications (oxycodone, hydrocodone, codeine, morphine, fentanyl, buprenorphine) — the combination may require dose reduction and close monitoring; some opioids like alfentanil are specifically flagged as "Avoid or Use Alternate Drug"

Benzodiazepines (alprazolam, diazepam, clonazepam, lorazepam) — additive CNS depression; common combination in epilepsy management, so both drugs are often dosed carefully when used together

Alcohol — Alcohol is a CNS depressant and significantly amplifies Spritam's sedating effects. Alcohol also lowers the seizure threshold independently, making it dangerous for epilepsy patients in general.

Tricyclic antidepressants (amitriptyline, nortriptyline, amoxapine) — additive sedation; also, TCAs can lower seizure threshold

Antipsychotics (quetiapine, olanzapine, haloperidol, aripiprazole, amisulpride) — additive sedation; closely monitor when combining

Sedating antihistamines (diphenhydramine / Benadryl, doxylamine) — additive sedation; check OTC cold and allergy products

Muscle relaxants (baclofen, cyclobenzaprine, carisoprodol) — additive CNS depression

Brexanolone and other neurosteroids — additive sedation; monitor closely

2. Deferiprone (Avoid — Myelosuppression Risk)

Deferiprone is a drug used to treat iron overload. Levetiracetam and deferiprone can each cause neutropenia (low white blood cells). Using them together increases this risk synergistically. Unless there is no safe alternative, this combination should be avoided. If co-administration is unavoidable, white blood cell counts should be monitored closely.

3. Myelosuppressive Agents

Drugs that suppress bone marrow (chemotherapy agents, some immunosuppressants, acalabrutinib, and others) can have additive bone marrow suppression effects with levetiracetam. This is particularly relevant for cancer patients who may be receiving both antiepileptic therapy and chemotherapy. Monitoring of complete blood counts is important.

4. Other Antiepileptic Drugs (AEDs)

Levetiracetam generally has minimal pharmacokinetic interactions with other AEDs — it doesn't significantly raise or lower blood levels of most AEDs and they don't significantly affect its levels. However, some pharmacodynamic interactions exist:

Carbamazepine — may slightly increase the clearance of levetiracetam (via enzyme induction), possibly reducing Spritam blood levels slightly. This is typically not clinically significant.

Phenytoin and phenobarbital — similar minor induction effect; does not typically require dose adjustment

Valproate — minimal interaction; some clinicians note that the combination may slightly increase levetiracetam-related behavioral side effects

5. Pregnancy: Levetiracetam Levels Drop

During pregnancy, physiological changes cause levetiracetam blood levels to decrease — often significantly during the third trimester. This is not a traditional drug-drug interaction but is critically important for pregnant patients. Doses may need to be increased during pregnancy to maintain seizure control, and then reduced again after delivery. Close monitoring with your neurologist throughout pregnancy is essential.

6. Renal Impairment: Dose Adjustment Required

Levetiracetam is primarily excreted through the kidneys. Patients with reduced kidney function (low creatinine clearance) will have slower drug clearance, leading to higher blood levels for a given dose. Dose adjustments are required based on creatinine clearance, and supplemental doses should be given after dialysis. Your doctor will calculate the appropriate dose for your kidney function.

What to Tell Your Doctor and Pharmacist

Always tell your prescribing doctor and pharmacist about ALL medications you take, including:

All prescription medications (including other seizure medications)

OTC medications (especially sleep aids, allergy pills, or cold medicines containing sedating antihistamines or alcohol)

Supplements and vitamins (some herbal supplements affect seizure threshold)

Alcohol consumption habits

Whether you are pregnant, planning pregnancy, or breastfeeding

Also see: Spritam Side Effects: What to Expect and How Does Spritam Work?.